Literature DB >> 1109176

Defect in insulin binding to receptors in obese man. Amelioration with calorie restriction.

J A Archer, P Gorden, J Roth.   

Abstract

With insulin at 0.1 ng/ml, the binding of (125I)insulin in vitro to circulating lymphocytes from 11 obese patients was less than that observed with cells from 10 thin volunteers. Furthermore, with obese cells, unlabeled insulin was less effective in competing with labeled hormone for binding, both at low and high concentrations of unlabeled insulin. These differences were not accounted for by the high concentrations of insulin in the circulation of the obese patients at the time fthe blood was drawn, or by differences in degradation of hormone, or in the characteristics of the cell population. The decrease in binding appears to be due to a lowering of the receptor concentration, but some loss of affinity has not been excluded. Institution of a calorie restricted diet (nine patients) which ameliorated the hyperinsulinemia, produced an improvement in hormone binding. Since the insulin receptors of lymphocytes in metabolic disorders seem to reflect the state of insulin receptors or target cells such as liver and fat, the lymphocytes or other leukocytes appear to be ideal for studies of impaired cell responsiveness to hormones in man.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1109176      PMCID: PMC301728          DOI: 10.1172/JCI107907

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Insulin interactions with its receptors: experimental evidence for negative cooperativity.

Authors:  P de Meyts; J Roth; D M Neville; J R Gavin; M A Lesniak
Journal:  Biochem Biophys Res Commun       Date:  1973-11-01       Impact factor: 3.575

2.  Quantitative aspects of the insulin-receptor interaction in liver plasma membranes.

Authors:  C R Kahn; P Freychet; J Roth; D M Neville
Journal:  J Biol Chem       Date:  1974-04-10       Impact factor: 5.157

3.  Thymic lymphocytes in obese (ob-ob) mice. A mirror of the insulin receptor defect in liver and fat.

Authors:  A H Soll; I D Goldfine; J Roth; C R Kahn
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

Review 4.  Peptide hormone binding to receptors: a review of direct studies in vitro.

Authors:  J Roth
Journal:  Metabolism       Date:  1973-08       Impact factor: 8.694

5.  Insulin action in isolated rat thymocytes. I. Binding of 125 I-insulin and stimulation of -aminoisobutyric acid transport.

Authors:  I D Goldfine; J D Gardner; D M Neville
Journal:  J Biol Chem       Date:  1972-11-10       Impact factor: 5.157

6.  Insulin-receptor interaction in the obese-hyperglycemic mouse. A model of insulin resistance.

Authors:  C R Kahn; D M Neville; J Roth
Journal:  J Biol Chem       Date:  1973-01-10       Impact factor: 5.157

7.  Characteristics of the human lymphocyte insulin receptor.

Authors:  J R Gavin; P Gorden; J Roth; J A Archer; D N Buell
Journal:  J Biol Chem       Date:  1973-03-25       Impact factor: 5.157

8.  Isolation of normal T cells in chronic lymphatic leukaemia.

Authors:  J Wybran; S Chantler; H H Fudenberg
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

9.  Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture.

Authors:  J R Gavin; J Roth; D M Neville; P de Meyts; D N Buell
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

10.  Insulin receptors in the liver: specific binding of ( 125 I)insulin to the plasma membrane and its relation to insulin bioactivity.

Authors:  P Freychet; J Roth; D M Neville
Journal:  Proc Natl Acad Sci U S A       Date:  1971-08       Impact factor: 11.205

View more
  53 in total

1.  Nutrition and insulin dependent diabetes in the young: general approaches.

Authors:  L Pinelli; A Olivieri; C Maffeis; E Gonfiantini
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

Review 2.  Interactions polypeptide hormones with cell membrane specific receptors: studies with insulin and glucagon.

Authors:  P Freychet
Journal:  Diabetologia       Date:  1976-05       Impact factor: 10.122

3.  Influence of cell size on the effects of insulin and noradrenaline on human adipose tissue.

Authors:  B Jacobsson; G Holm; P Björntorp; U Smith
Journal:  Diabetologia       Date:  1976-03       Impact factor: 10.122

4.  Insulin receptor deficiency in genetic and acquired obesity.

Authors:  A H Soli; C R Kahn; D M Neville; J Roth
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

5.  Changes in insulin receptor functions of the erythrocyte by treatment of non-insulin-dependent diabetes mellitus (NIDDM) patients with glibenclamide and diet control.

Authors:  V R Agarwal; A K Rastogi; C G Agarwal; P Sagar
Journal:  Acta Diabetol Lat       Date:  1986 Jul-Sep

6.  Insulin receptors and insulin sensitivity in normo and hyperinsulinemic obese patients.

Authors:  A Carducci Artenisio; F Ragonese; F Forte; G Saitta; G Perrone; G Lettina; R Campisi; F Consolo
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

7.  Infusion of insulin impairs human adipocyte glucose metabolism in vitro without decreasing adipocyte insulin receptor binding.

Authors:  L Mandarino; B Baker; R Rizza; J Genest; J Gerich
Journal:  Diabetologia       Date:  1984-09       Impact factor: 10.122

8.  Relationship between body fat mass, carbohydrate tolerance and IRI response during glucose infusion in subjects with early diabetes.

Authors:  K P Ratzmann; S Knospe; P Heinke; B Schulz
Journal:  Acta Diabetol Lat       Date:  1979 Jan-Mar

9.  Sex differences in weight loss among adults with type II diabetes mellitus.

Authors:  C A Heitzmann; R M Kaplan; D K Wilson; J Sandler
Journal:  J Behav Med       Date:  1987-04

10.  The effects of energy and carbohydrate restriction in patients with chronic diabetes mellitus.

Authors:  J R Perkins; T E West; P H Sönksen; C Lowy; C Iles
Journal:  Diabetologia       Date:  1977-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.